Evidence map›Paper›PMID 36066412›Full record

ArticleJournal of medicinal chemistry2022

Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.

Peter Obi, Senthil Natesan

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. OrthogonalApplied and environmental microbiology · 2025
    Article
  4. Bitopic AJournal of medicinal chemistry · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Peter ObiCollege of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington 99202, United States.
Senthil NatesanCollege of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington 99202, United States.ORCID 0000-0001-5347-6940
Washington State University Spokane · US

Funding

Molecular biophysics of integrin activation by oxysterols and rational discovery of small-molecule modulatorsR01GM137022 · NIGMS · WASHINGTON STATE UNIVERSITY · PI NATESAN, SENTHIL KUMAR · 2020 to 2023
$1.2M
Specifics of "Non-Specific Membrane Interactions" of Drugs: An Integrated Approach for Understanding Structure-Membrane Interaction RelationshipsR15GM131293 · NIGMS · WASHINGTON STATE UNIVERSITY · PI NATESAN, SENTHIL KUMAR · 2018 to 2018
$458k
NIGMS NIH HHS R01 GM137022NIGMS NIH HHS R15 GM131293
6 · The paper itself

Abstract

A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. The experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand access and binding is often overlooked and poorly understood. Using classical and enhanced molecular dynamics simulations, we show that membrane lipids are critical in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor. The observed differences in the binding affinity and cooperativity arise from the functional groups that interact primarily with lipids. Our results demonstrate the significance of incorporating membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity calculations, and lead optimization in drug discovery.

Indexed as

CannabinoidsReceptor, Cannabinoid, CB1Allosteric RegulationAllosteric SiteIndolesLigandsMembrane LipidsPiperidinesProtein BindingReceptors, G-Protein-Coupled5-chloro-3-ethyl-1H-indole-2-carboxylic acid (2-(4-piperidin-1-yl-phenyl)ethyl)amideCannabinoidsIndolesLigandsMembrane LipidsPiperidinesReceptor, Cannabinoid, CB1Receptors, G-Protein-Coupled

Identifiers

PMID36066412
PMCPMC9512009
OpenAlexW4294783602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.